228 related articles for article (PubMed ID: 1900959)
1. Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans.
Andersen ME; Clewell HJ; Gargas ML; MacNaughton MG; Reitz RH; Nolan RJ; McKenna MJ
Toxicol Appl Pharmacol; 1991 Mar; 108(1):14-27. PubMed ID: 1900959
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of three physiologically based pharmacokinetic (PBPK) modeling tools for emergency risk assessment after acute dichloromethane exposure.
Boerleider RZ; Olie JD; van Eijkeren JC; Bos PM; Hof BG; de Vries I; Bessems JG; Meulenbelt J; Hunault CC
Toxicol Lett; 2015 Jan; 232(1):21-7. PubMed ID: 25455448
[TBL] [Abstract][Full Text] [Related]
3. Assessing the relevance of rodent data on chemical interactions for health risk assessment purposes: a case study with dichloromethane-toluene mixture.
Pelekis M; Krishnan K
Regul Toxicol Pharmacol; 1997 Feb; 25(1):79-86. PubMed ID: 9056503
[TBL] [Abstract][Full Text] [Related]
4. Prediction of carboxyhemoglobin formation due to transient exposure to carbon monoxide.
Benignus VA; Hazucha MJ; Smith MV; Bromberg PA
J Appl Physiol (1985); 1994 Apr; 76(4):1739-45. PubMed ID: 8045854
[TBL] [Abstract][Full Text] [Related]
5. Predicting the carboxyhemoglobin levels resulting from carbon monoxide exposures.
Peterson JE; Stewart RD
J Appl Physiol; 1975 Oct; 39(4):633-8. PubMed ID: 1194155
[TBL] [Abstract][Full Text] [Related]
6. Physiologically based pharmacokinetic modeling of the pregnant rat: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid.
Fisher JW; Whittaker TA; Taylor DH; Clewell HJ; Andersen ME
Toxicol Appl Pharmacol; 1989 Jul; 99(3):395-414. PubMed ID: 2749729
[TBL] [Abstract][Full Text] [Related]
7. A multicompartment model of carboxyhemoglobin and carboxymyoglobin responses to inhalation of carbon monoxide.
Bruce EN; Bruce MC
J Appl Physiol (1985); 2003 Sep; 95(3):1235-47. PubMed ID: 12754170
[TBL] [Abstract][Full Text] [Related]
8. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride.
Andersen ME; Clewell HJ; Gargas ML; Smith FA; Reitz RH
Toxicol Appl Pharmacol; 1987 Feb; 87(2):185-205. PubMed ID: 3824380
[TBL] [Abstract][Full Text] [Related]
9. DNA-protein cross-links (DPX) and cell proliferation in B6C3F1 mice but not Syrian golden hamsters exposed to dichloromethane: pharmacokinetics and risk assessment with DPX as dosimeter.
Casanova M; Conolly RB; Heck H d'A
Fundam Appl Toxicol; 1996 May; 31(1):103-16. PubMed ID: 8998946
[TBL] [Abstract][Full Text] [Related]
10. Physiological modeling reveals novel pharmacokinetic behavior for inhaled octamethylcyclotetrasiloxane in rats.
Andersen ME; Sarangapani R; Reitz RH; Gallavan RH; Dobrev ID; Plotzke KP
Toxicol Sci; 2001 Apr; 60(2):214-31. PubMed ID: 11248133
[TBL] [Abstract][Full Text] [Related]
11. Percent carboxyhemoglobin in resting humans exposed repeatedly to 1,500 and 7,500 ppm CO.
Tikuisis P; Buick F; Kane DM
J Appl Physiol (1985); 1987 Aug; 63(2):820-7. PubMed ID: 3654442
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of inhaled dihalomethanes in vivo: differentiation of kinetic constants for two independent pathways.
Gargas ML; Clewell HJ; Andersen ME
Toxicol Appl Pharmacol; 1986 Feb; 82(2):211-23. PubMed ID: 3945949
[TBL] [Abstract][Full Text] [Related]
13. A physiologically based pharmacokinetic model for inhaled carbon tetrachloride.
Paustenbach DJ; Clewell HJ; Gargas ML; Andersen ME
Toxicol Appl Pharmacol; 1988 Nov; 96(2):191-211. PubMed ID: 3143166
[TBL] [Abstract][Full Text] [Related]
14. Estimation of interindividual variation in oxidative metabolism of dichloromethane in human volunteers.
Sweeney LM; Kirman CR; Morgott DA; Gargas ML
Toxicol Lett; 2004 Dec; 154(3):201-16. PubMed ID: 15501612
[TBL] [Abstract][Full Text] [Related]
15. Rate of formation of carboxyhemoglobin in exercising humans exposed to carbon monoxide.
Tikuisis P; Kane DM; McLellan TM; Buick F; Fairburn SM
J Appl Physiol (1985); 1992 Apr; 72(4):1311-9. PubMed ID: 1592720
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of inhalation exposure to carbon monoxide on schedule-controlled operant behavior and blood carboxyhemoglobin levels in rats.
Miyagawa M; Honma T; Sato M; Hasegawa H
Ind Health; 1995; 33(3):119-29. PubMed ID: 8543475
[TBL] [Abstract][Full Text] [Related]
17. A physiological model for predicting carboxyhemoglobin formation from exposure to carbon monoxide in rats.
Kimmel EC; Carpenter RL; Reboulet JE; Still KR
J Appl Physiol (1985); 1999 Jun; 86(6):1977-83. PubMed ID: 10368364
[TBL] [Abstract][Full Text] [Related]
18. Gas uptake studies of deuterium isotope effects on dichloromethane metabolism in female B6C3F1 mice in vivo.
Andersen ME; Clewell HJ; Mahle DA; Gearhart JM
Toxicol Appl Pharmacol; 1994 Sep; 128(1):158-65. PubMed ID: 8079349
[TBL] [Abstract][Full Text] [Related]
19. Neurotoxicologic evaluation of rats after 13 weeks of inhalation exposure to dichloromethane or carbon monoxide.
Mattsson JL; Albee RR; Eisenbrandt DL
Pharmacol Biochem Behav; 1990 Jul; 36(3):671-81. PubMed ID: 2377667
[TBL] [Abstract][Full Text] [Related]
20. PB-PK derived metabolic constants, hepatotoxicity, and lethality of BrCCl3 in rats pretreated with chlordecone, phenobarbital, or mirex.
Thakore KN; Gargas ML; Andersen ME; Mehendale HM
Toxicol Appl Pharmacol; 1991 Jul; 109(3):514-28. PubMed ID: 1712992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
